Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 33 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $883K 7,796 sh | May 1, 2026 |
| 33 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $991K 8,834 sh | May 1, 2026 traded Apr 29, 2026 |
| 33 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $418K 3,754 sh | May 1, 2026 traded Apr 29, 2026 |
| 32 | Durr LauraDirector |  OWLTOwlet, Inc.Grant or award | A | — 19.0K sh | May 1, 2026 traded Oct 16, 2025 |
| 32 | Cashman SteveChief Business Officer |  BFLYButterfly Network, Inc.Open-market sale | SELL | $724K 147.5K sh | May 1, 2026 traded Apr 29, 2026 |
| 30 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $248K 2,208 sh | May 1, 2026 traded Apr 29, 2026 |
| 30 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $221K 1,950 sh | May 1, 2026 traded Apr 29, 2026 |
| 30 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $105K 939 sh | May 1, 2026 traded Apr 29, 2026 |
| 28 | Larabee Brian KeithSVP & GM - EMS |  ROGROGERS CORPOpen-market sale | SELL | $113K 830 sh | May 1, 2026 traded May 1, 2026 |
| 28 | Sloan SheldonChief Medical Officer |  SYRESpyre Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $764K 10.4K sh | May 1, 2026 traded May 1, 2026 |
| 28 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $377K 5,059 sh | May 1, 2026 traded May 1, 2026 |
| 27 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.48M 21.3K sh | May 1, 2026 traded May 1, 2026 |
| 27 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.39M 19.7K sh | May 1, 2026 traded May 1, 2026 |
| 26 | Sullivan Christopher RyanChief Financial Officer |  AVTXAvalo Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $112K 8,457 sh | May 1, 2026 traded Apr 30, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $203K 1,840 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $111K 8,458 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Young Tobi M.Director |  HALHALLIBURTON COOpen-market sale | SELL | $21K 500 sh | May 1, 2026 traded Apr 30, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $57K 520 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $226K 2,080 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Schwartz Richard ToddDirector, Chief Executive Officer |  RSIRush Street Interactive, Inc.Open-market sale · 10b5-1 plan | SELL | $1.33M 47.2K sh | May 1, 2026 traded May 1, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $190K 1,760 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $51K 460 sh | May 1, 2026 traded Apr 29, 2026 |
| 25 | Cox John DDirector |  NWWPNEW PEOPLES BANKSHARES INCOpen-market purchase | BUY | $33K 8,570 sh | May 1, 2026 traded Apr 30, 2026 |
| 25 | Schmidt MarianneEXECUTIVE OFFICER |  EFSIEAGLE FINANCIAL SERVICES INCOpen-market sale | SELL | $15K 388 sh | May 1, 2026 traded Apr 29, 2026 |
| 24 | DiVito Joseph V. JrDirector |  FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/Grant or award | A | $51K 2,790 sh | May 1, 2026 traded May 1, 2026 |
| 24 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $932K 12.8K sh | May 1, 2026 traded May 1, 2026 |
| 24 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $628K 8,777 sh | May 1, 2026 traded May 1, 2026 |
| 23 | Hardy AndrewEVP, Chief Sales Officer |  NXPINXP Semiconductors N.V.Tax withholding | F | $718K 2,483 sh | May 1, 2026 traded Apr 30, 2026 |
| 23 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $47K 440 sh | May 1, 2026 traded Apr 29, 2026 |
| 23 | Stetz MattiasChief Operating Officer | RSIRush Street Interactive, Inc. Open-market sale · 10b5-1 plan | SELL | $562K 20.0K sh | May 1, 2026 traded May 1, 2026 |
| 22 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $30K 400 sh | May 1, 2026 traded May 1, 2026 |
| 22 | Palmer Stephen RVice President of Accounting |  CVNACARVANA CO.Open-market sale · 10b5-1 plan | SELL | $395K 1,000 sh | May 1, 2026 traded May 1, 2026 |
| 21 | McIntyre ShaunaDirector |  LADLITHIA MOTORS INCGrant or award | A | — 715 sh | May 1, 2026 traded Apr 30, 2026 |
| 21 | Perl JessicaSVP, General Counsel, Corp Sec |  EBSEmergent BioSolutions Inc.Grant or award | A | — 104.3K sh | May 1, 2026 traded Apr 29, 2026 |
| 21 | Polzin WardDirector |  CHRDChord Energy CorpGrant or award | A | — 1,524 sh | May 1, 2026 traded Apr 29, 2026 |
| 21 | Prince John MichaelDirector |  CTEVClaritev CorpGrant or award | A | — 8,977 sh | May 1, 2026 traded Apr 29, 2026 |
| 21 | Saldana Madero RogerSenior Vice President of Legal |  CXCEMEX SAB DE CVGrant or award | A | — 37.1K sh | May 1, 2026 traded May 1, 2026 |
| 21 | Hartzel WilliamSVP, Bioservices | EBSEmergent BioSolutions Inc. Grant or award | A | — 100.1K sh | May 1, 2026 traded Apr 29, 2026 |
| 21 | Gonzalez Flores Jose AntonioEVP Strat. Plan. & Bus. Dev. | CXCEMEX SAB DE CV Grant or award | A | — 74.1K sh | May 1, 2026 traded May 1, 2026 |
| 21 | Ramirez Cantu Alejandro AlbertoPresident of Cemex SCA&C | CXCEMEX SAB DE CV Grant or award | A | — 50.1K sh | May 1, 2026 traded May 1, 2026 |